Landaas & CO Oramed Pharmaceuticals Inc. Transaction History

Landaas & CO

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 14, 2018	SELL	$4.64 - $7.11 $1,067 - $1,635	-230 Closed	0 $0
Q2 2018 Aug 07, 2018	BUY	$6.29 - $8.22 $1,446 - $1,890	230 New	230 $2,000
Q1 2018 May 14, 2018	SELL	$6.51 - $9.14 $1,497 - $2,102	-230 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$7.74 - $10.78 $1,780 - $2,479	230	230 $2,000

6.37M

Ticker ORMP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,827,100
Market Cap $91.2M
Description
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for th...

Get notified when there are updates to the investment portfolio of Landaas & CO , based on Form 13F filings with the SEC.

Stay updated on Landaas & CO with notifications on news.